Upadacitinib safe and effective in PsA patients with axial involvementMay 18, 2023Psoriatic Arthritis
Sonographic enthesitis associated with sonographic synovitis and tenosynovitis in PsAMay 18, 2023Psoriatic Arthritis
Secukinumab improves treatment outcomes and inhibits structural damage in PsAMay 18, 2023Psoriatic Arthritis
Rheumatology NewsBrepocitinib shows promise for psoriatic arthritis patientsMay 17, 2023Psoriatic Arthritis
Rheumatology NewsAxial spondyloarthritis versus axial psoriatic arthritis: Different entities?May 9, 2023Psoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsCOVID-19 and psoriasis: Is there a link?May 4, 2023COVID-19 UpdatesPsoriatic Arthritis
Rheumatology NewsMeta-analysis examines cancer risk concern for JAK inhibitorsApril 26, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsNPF provides guidance for virtual psoriasis visitsApril 24, 2023Business of MedicinePsoriatic Arthritis
Study identifies risk factors associated with PsA occurrence in patients with psoriasisApril 18, 2023Psoriatic Arthritis
Patients with PsA have lower vitamin D levels than general population, says meta-analysisApril 18, 2023Psoriatic Arthritis
Vitamin D deficiency associated with lowest retention rates of first bDMARD in PsAApril 18, 2023Psoriatic Arthritis
